๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Problems with peritoneal cytology in second-look laparotomy performed in patients with epithelial ovarian carcinoma

โœ Scribed by Ohwada, Michitaka ;Suzuki, Mitsuaki ;Suzuki, Tatsuya ;Hiratsuka, Mitsuhiro ;Kawai, Toshiro ;Saito, Ken ;Sato, Ikuo


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
147 KB
Volume
93
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND.

The recurrence rate of ovarian carcinoma is high even when a second-look laparotomy (SLL) is negative. In the current study, the accuracy of peritoneal cytology as an evaluation method of SLL was examined.

METHODS.

The positive SLL rate and the diagnostic accuracy of peritoneal cytology were evaluated in 101 patients with epithelial ovarian carcinoma.

RESULTS.

Twenty-three of the 101 patients (23%) were positive based on SLL. The factors considered to be high risk factors for a positive SLL were advanced disease (Stages III and IV by the International Federation of Gynecology and Obstetrics

[FIGO] classification), serous adenocarcinoma, and maximum residual tumor ฯพ 2 cm after primary surgery (P ฯฝ 0.05). Of the 23 patients found to be positive on SLL, peritoneal cytology was positive in 6 patients, in whom the percentage was low (26%). The remaining 17 patients (74%) demonstrated false-negative cytology. Of these 17 patients, the tumor tissues were found to be capsulated completely with connective tissues in all biopsy specimens from 9 patients (53%) and in all but 1 biopsy specimen in 6 patients (35%), together accounting for a capsulation rate of 88%. Conversely, clear exposure of the tumor tissues was observed in at least two biopsy specimens in those patients demonstrating positive cytology (P ฯฝ 0.01).

CONCLUSIONS.

Peritoneal cytology in SLL was found to result in a high falsenegative rate. One of the reasons for this was considered to be capsulation of the lesions with proliferated connective tissues, which may have been the result of by chemotherapy. Cancer (Cancer Cytopathol) 2001;93:376 -80.


๐Ÿ“œ SIMILAR VOLUMES


Prognosticators of second-look laparotom
โœ Professor Dr. Ali Ayhan; Hakan Yarali; Osman Develioวงlu; Aykut รœren; Filiz ร–zyil ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 328 KB

Prognosticators of outcome at second-look laparotomy (SLL) were evaluated in 49 patients with epithelial ovarian carcinoma undergoing SLL. Residual tumor volume was found to be the most significant prognosticator of outcome, with initial tumor stage being of secondary importance. Grade of tumor play

Efficacy of low-dose topotecan in second
โœ Bo Gronlund; Heine H. Hansen; Claus Hรธgdall; Svend A. Engelholm ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB

## Abstract ## BACKGROUND The high incidence of doseโ€limiting myelosuppresion using the U.S. Food and Drug Administrationโ€approved topotecan dose of 1.5 mg/m^2^ for 5 days every 3 weeks may have limited its utility in the treatment of patients with epithelial ovarian carcinoma. The objective of th

A Phase I trial of intravenous melphalan
โœ David M. Gershenson; Mitchell Morris; Thomas W. Burke; Charles Levenback; Judith ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 96 KB ๐Ÿ‘ 2 views

The primary purpose of this study was to establish the maximum tolerated dose (MTD) of intravenous melphalan in combination with paclitaxel and cisplatin plus granulocyte-colony stimulating factor (G-CSF) in patients with suboptimal advanced epithelial ovarian carcinoma or primary peritoneal carcino